G-CSF is recommended in primary or secondary prophylaxis subsequently to chemotherapy at high risk of neutropenia leading to a reduction of infection, infection-related mortality and all-cause mortality [19, 20]. Here, CSF3 is linked to Decreased total neutrophil count.